Neuromeka

A publicly listed South Korean cobot maker with genuine in-house integration depth, a credible domestic market position, and financial losses that demand scrutiny before the growth narrative is accepted.

---

How to Read This Report

This report applies a four-tier evidence discipline to every substantive claim. Readers should treat these labels as load-bearing, not decorative.

A choreographed demo video is not proof of autonomous capability. A partnership announcement is not proof of a paying customer. A shipment is not proof of productive deployment. Where the research dossier is thin, this report says so plainly rather than filling the gap with inference dressed as fact.

---

01Executive Overview

Neuromeka Co., Ltd. is a South Korean collaborative robot manufacturer, publicly listed on the KOSDAQ exchange (ticker: 348340) since its IPO, with a market capitalisation of approximately KRW 623 billion (roughly USD 450 million at prevailing rates) ⁶. Founded in Seoul in 2013 by Park Jong-hoon, who retains a 20.29% majority stake and holds an adjunct professorship at POSTECH's Mechanical Engineering department, the company occupies a distinctive position in the global cobot landscape: it is one of the very few manufacturers outside of Europe, Japan, and the United States to have developed motors, harmonic reducers, smart actuators, and robot controllers entirely in-house ²⁸.

The company's core commercial product is the Indy series of collaborative robot arms, sold and leased into manufacturing automation, food and beverage service, and welding applications. Its OPTi series targets shipbuilding and heavy-industry welding. Its NURI series covers autonomous mobile robots. A humanoid platform exists at an earlier stage of development. The CORE smart actuator — integrating a frameless motor, harmonic drive, magnetic brake, multi-turn absolute encoder, EtherCAT slave board, and motor driver into a single module — is the technological centrepiece that underpins the company's vertical integration argument ⁴.

VERIFIED: Neuromeka's Indy7 cobot is commercially available at a list price of €23,400 excluding VAT, with a leasing option from €1,000 per month ⁵. A confirmed mass-production deployment exists at DN Automotive's production line ¹³. The company holds NSF food-safety certification for relevant products ¹⁰.

VERIFIED: Trailing twelve-month revenue stands at KRW 18.77–18.95 billion, representing a decline of approximately 25% year-on-year from KRW 25.27 billion. The net loss for the same period is KRW 40.28 billion ⁶⁹. These are public market figures and are not in dispute.

The central tension in the Neuromeka investment and commercial thesis is the gap between its market-position narrative and its financial trajectory. The company claims the number-one annual revenue position in Korea's collaborative robot market for 2024 ¹². That claim is not independently verified and sits awkwardly against a 25% revenue contraction and a net loss more than twice the size of annual revenue. The two data points are not logically irreconcilable — one can lead a small, contracting domestic market while simultaneously burning cash on R&D and international expansion — but the framing requires careful unpacking rather than acceptance at face value.

EDITORIAL INFERENCE: The financial profile is consistent with a company in a deliberate investment phase, absorbing costs of in-house component development, international market entry (Hannover Messe presence, European distribution via Unchained Robotics), and humanoid platform development. Whether the investment phase resolves into sustainable revenue growth or into a prolonged cash-burn problem is the defining question for any stakeholder.

The autonomy classification for Neuromeka's deployed robots is Autonomous in the industrial-task sense: once programmed and integrated, the Indy series executes machine tending, welding, and production-line tasks without human operators performing those tasks. This is conventional programmed cobot autonomy, not AI-driven open-ended task judgment, regardless of the company's marketing language ⁷¹³.

Latest news

This module is being compiled — no data to show yet.

---

02The Neuromeka Story

Founding and Academic Roots

Neuromeka was founded in 2013 in Seoul, South Korea ¹². The founding context matters: 2013 was the year Universal Robots was beginning its international expansion following its 2012 acquisition by Teradyne, and the global cobot category was still nascent. Park Jong-hoon, the founder and CEO, is simultaneously an adjunct professor in Mechanical Engineering at POSTECH (Pohang University of Science and Technology), one of South Korea's most technically rigorous research universities ². This dual role — academic researcher and commercial CEO — is a structural feature of many deep-tech Korean startups and has implications for both the company's R&D orientation and its governance. POSTECH's mechanical engineering programme has a strong robotics tradition, and the academic connection plausibly explains Neuromeka's early commitment to in-house component development rather than the more commercially expedient route of assembling cobots from third-party actuators and controllers.

UNKNOWN: The precise founding team composition beyond Park Jong-hoon, the initial research-to-commercialisation pathway, and whether any POSTECH intellectual property was licensed or transferred at founding are not publicly disclosed.

The In-House Integration Bet

The strategic decision that most distinguishes Neuromeka from the majority of cobot manufacturers globally is its commitment to developing every major drivetrain and control component internally. The company claims to be the first in Korea to achieve this ²⁸. The CORE smart actuator — which integrates a frameless motor, harmonic drive, magnetic brake, multi-turn absolute encoder, EtherCAT slave board, and motor driver into a single compact module — is the physical embodiment of this strategy ⁴. Harmonic reducers (also called strain wave gears) are the precision gearing mechanism that gives cobot joints their low-backlash, high-torque-density characteristics. They are notoriously difficult to manufacture to the tolerances required for repeatable robot motion, and the global supply has historically been dominated by Harmonic Drive AG (Germany/Japan) and a small number of Japanese and Chinese manufacturers.

VERIFIED: The CORE actuator integrates all six listed components ⁴⁸. The claim of being first in Korea to achieve full in-house development is a company claim corroborated as a key differentiator in the Korea Institute of Robot and Convergence (KIRS) research report ⁷, though independent technical validation of the harmonic reducer's performance relative to established suppliers is not available in the public dossier.

The strategic logic of vertical integration in robotics is well-established: it reduces supply-chain exposure, enables tighter hardware-software co-optimisation, and — in theory — improves margins at scale. The risk is that the capital and engineering resources required to develop and manufacture precision components internally are substantial, and the learning curve is long. Neuromeka's current financial losses are at least partly attributable to this bet.

KOSDAQ Listing and Investor Base

VERIFIED: Neuromeka is publicly listed on the KOSDAQ exchange under ticker 348340 ⁶. Total external funding prior to and including the IPO is approximately USD 36.5 million ¹². In March 2025, DN Solutions — a major South Korean machine tool manufacturer — invested KRW 5 billion (approximately USD 3.7 million) in a post-IPO round ¹¹. This investment is strategically significant: DN Solutions is a downstream customer and integration partner, and its financial commitment signals confidence in Neuromeka's machine-tending cobot capability. The confirmed DN Automotive deployment ¹³ is consistent with a DN group ecosystem relationship, though the precise commercial terms and volume are not publicly disclosed.

VERIFIED: Other investors include Kolon Investments and Lighthouse Investment Partners ¹². Kolon is a major South Korean industrial conglomerate with interests in materials, chemicals, and manufacturing — a strategically relevant backer for an industrial automation company.

Internationalisation Trajectory

VERIFIED: Neuromeka exhibited at Hannover Messe 2024, the world's largest industrial trade fair, and produced an English-language company profile for that event ⁸. Its Indy7 is listed for sale in Europe through Unchained Robotics, a German-based cobot marketplace, at a published Euro price ⁵. These are concrete indicators of a deliberate European market entry strategy.

UNKNOWN: Revenue breakdown by geography, the number of active European customers, and the volume of units shipped outside South Korea are not publicly disclosed. The presence on a European marketplace does not constitute evidence of European sales volume.

Awards and Recognition

COMPANY CLAIM: Neuromeka cites the WFT ConfEx 2026 top award, the China Chapek Award for Humanoid Robot Technology Innovation Product, and KOSDAQ Rising Star recognition ¹⁷. These awards are noted for completeness. Industry awards, particularly those from conference organisers and trade bodies, carry limited evidentiary weight regarding technical capability or commercial traction.

---

03Product Portfolio: What Neuromeka Actually Sells

Neuromeka's commercial portfolio spans four distinct hardware lines plus a component business. The following table summarises the verified product lines and their primary applications.

Indy Series

The Indy7 is the best-documented product in the public record. At 7 kg payload and 1,300 mm reach, it sits in the mainstream collaborative robot segment — comparable in envelope to Universal Robots' UR10 and similar offerings from Doosan Robotics and Techman Robot ⁵. The ±0.1 mm repeatability specification is standard for the category. The 1 m/s maximum TCP speed is at the lower end of the competitive range for cobots of this payload class, which is a point worth noting for applications requiring high cycle rates.

VERIFIED: The Indy7 is available for purchase at €23,400 excluding VAT, or on a monthly lease from €1,000 per month through the IndyGO subscription model ⁵. The leasing model is explicitly positioned at SME manufacturers who cannot absorb large capital expenditure ⁸.

UNKNOWN: The full Indy series range (Indy3, Indy5, Indy10, and any other variants) is referenced in the company's broader communications but detailed specifications for variants other than the Indy7 are not present in the research dossier.

NURI3s

The NURI3s is a more compact arm with notably tighter repeatability (±0.02 mm versus ±0.1 mm for the Indy7), which is unusual — smaller, lighter arms do not automatically achieve better repeatability, and this specification would benefit from independent validation ⁸. The IP54 rating makes it suitable for environments with dust and water splash, relevant for food and beverage applications. The NSF certification for food safety ¹⁰ is a meaningful third-party credential for F&B deployment.

OPTi Series

The OPTi series is described as welding-specialised and has been deployed in shipbuilding block welding ⁷⁸. South Korea's shipbuilding industry — dominated by Hyundai Heavy Industries, Samsung Heavy Industries, and Hanwha Ocean — is a strategically important domestic market for welding automation. Shipbuilding welding involves complex geometries, variable joint conditions, and demanding environments; the use of 3D camera guidance in the OPTi deployment context is mentioned in the KIRS report ⁷, suggesting sensor-guided rather than purely pre-programmed welding paths.

EDITORIAL INFERENCE: The OPTi series represents Neuromeka's highest-value application vertical in terms of technical complexity and potential contract size. Shipbuilding customers are sophisticated buyers with demanding qualification requirements, and a confirmed deployment in this sector is a more meaningful commercial signal than an F&B service installation.

NURI AMR Series

The NURI AMR line covers autonomous mobile robots for factory logistics. Detailed specifications are not present in the research dossier. The AMR market is highly competitive, with established players including Mobile Industrial Robots (MiR), Omron, and a large number of Chinese manufacturers. Neuromeka's competitive positioning in AMR relative to its cobot business is not clearly articulated in available sources.

Humanoid Platform

COMPANY CLAIM: Neuromeka has received the China Chapek Award for Humanoid Robot Technology Innovation Product ¹⁷, which implies a humanoid platform exists at a demonstrable stage. However, no specifications, deployment timeline, or commercial pricing are available in the public dossier. The humanoid platform should be treated as a development-stage asset, not a commercial product, until evidence of commercial availability or confirmed customer deployments emerges.

CORE Smart Actuator

The CORE actuator is both the foundation of Neuromeka's own robot joints and a potential OEM component business ⁴. The integration of six subsystems into a single module — frameless motor, harmonic drive, magnetic brake, multi-turn absolute encoder, EtherCAT slave board, and motor driver — is a genuine engineering achievement if the performance specifications are competitive with established suppliers. EtherCAT compatibility is the industrial fieldbus standard for real-time motion control, ensuring interoperability with standard industrial automation infrastructure.

EDITORIAL INFERENCE: If Neuromeka can establish the CORE actuator as a credible OEM component for third-party robot manufacturers, it opens a revenue stream independent of its own robot sales. This would be a meaningful business model diversification. There is no public evidence of OEM actuator customers at this time.

Products & versions

Indy7

7 kg payload, 1,300 mm reach collaborative robot arm with ±0.1 mm repeatability, available for purchase (€23,400) or lease (from €1,000/month).

Indy Series

Neuromeka's flagship line of collaborative robot arms for industrial automation, featuring in-house motors, harmonic reducers, and CORE smart actuators.

OPTi Series

Welding-specialized collaborative robot series designed for shipbuilding and industrial welding applications, including block welding with 3D camera guidance.

NURI Series (AMR)

Autonomous Mobile Robot (AMR) series; the NURI3s variant offers 3 kg payload, 6 DOF, ±0.02 mm repeatability, ≤3.0 m/s speed, 705 mm reach, and IP54 rating.

Humanoid Platform

Neuromeka's humanoid robot platform, recognized with the China Chapek Award for Humanoid Robot Technology Innovation Product.

CORE Smart Actuator

Fully in-house integrated smart actuator combining a frameless motor, harmonic drive, magnetic brake, multi-turn absolute encoder, EtherCAT slave board, and motor driver.

---

04Technology Stack: Strengths and the Work That Remains

Vertical Integration as a Technical Moat

The most substantiated technical claim Neuromeka makes is vertical integration of the drivetrain and control stack. The CORE actuator's integration of motor, harmonic reducer, brake, encoder, and EtherCAT-capable driver into a single module is verified by both the official product page and the Hannover Messe company profile ⁴⁸. The KIRS research report identifies this as a key differentiator in the Korean cobot market ⁷.

The practical significance of in-house harmonic reducer development deserves elaboration. Harmonic drives are the precision gearing mechanism that enables cobot joints to achieve the combination of high torque density, zero backlash, and compact form factor that the category requires. The global supply chain for harmonic reducers has historically been a bottleneck for cobot manufacturers: Harmonic Drive AG and a small number of Japanese suppliers (Nabtesco, Sumitomo) have dominated, and Chinese manufacturers (LEADERDRIVE, Zhuhai Jianpei) have entered the market at lower price points but with variable quality. A manufacturer that can produce its own harmonic reducers controls a critical cost and quality variable.

EDITORIAL INFERENCE: The in-house harmonic reducer capability, if it has reached production-quality consistency, represents a genuine supply-chain advantage. However, the financial losses suggest that the cost structure of in-house component manufacturing has not yet yielded the margin benefits that vertical integration theoretically promises. Either the volumes are too low to achieve manufacturing economies of scale, or the development costs are still being absorbed, or both.

Control Software and Programming Interface

COMPANY CLAIM: Neuromeka describes an "intelligent automation ecosystem" driven by "advanced AI technology" that enables robots to "autonomously judge and perform tasks" ¹. This language is not supported by the independent evidence in the dossier.

VERIFIED: The deployed use cases — machine tending at DN Automotive, shipbuilding block welding, F&B service — are programmed automation tasks. The welding application uses 3D camera guidance ⁷, which is sensor-guided path adaptation rather than open-ended AI task judgment. This is a meaningful capability but it is not the same as the AI autonomy the marketing language implies.

UNKNOWN: The specific programming environment, software development kit, simulation tools, and any machine learning frameworks integrated into the control stack are not described in detail in the public dossier. Whether Neuromeka offers a graphical teach-pendant interface, a block-based programming environment, or a ROS-compatible API is not confirmed in available sources.

Repeatability Claims

The NURI3s's stated repeatability of ±0.02 mm is notably tighter than the Indy7's ±0.1 mm ⁵⁸. For context, Universal Robots' UR3e achieves ±0.03 mm, and the UR5e achieves ±0.05 mm. A ±0.02 mm figure for a 3 kg payload arm is at the high end of what collaborative robots achieve and would be competitive with precision assembly cobots from Epson and Staubli. This specification has not been independently validated in the available dossier and warrants scrutiny.

EDITORIAL INFERENCE: Repeatability specifications in robot datasheets are often measured under idealised conditions (constant temperature, no load, specific measurement methodology per ISO 9283). Real-world repeatability under production conditions, thermal cycling, and varying payloads is typically worse. The ±0.02 mm claim for the NURI3s should be treated as a company claim pending independent validation.

Safety and Certification

VERIFIED: The NURI3s carries an IP54 rating ⁸. NSF certification for food safety has been obtained for relevant products ¹⁰. These are meaningful third-party certifications.

UNKNOWN: CE marking status for European market entry, ISO 10218 / ISO/TS 15066 collaborative robot safety compliance documentation, and UL certification status are not confirmed in the available dossier. For a company actively pursuing European sales through Unchained Robotics ⁵, CE marking would be a prerequisite; its absence from the public record is a gap that should be investigated rather than assumed.

Patents

COMPANY CLAIM: Neuromeka holds 19 patent categories covering 39 patent applications ¹. This is a modest portfolio for a 12-year-old robotics company with claimed full-stack in-house development. For comparison, established cobot manufacturers and their parent companies hold patent portfolios in the hundreds to thousands. The 39-application figure suggests either selective patenting, a focus on trade secrets over patents, or a portfolio that is still being built.

UNKNOWN: The specific technical domains covered by the patent applications, their jurisdictions, and their grant status are not publicly detailed in the available sources.

---

05Research, Papers, Authors and Labs

Academic Output and Research Posture

The research dossier contains zero entries in the research category (count: 0). This is a significant gap. For a company whose CEO holds an adjunct professorship at POSTECH and whose founding narrative is rooted in academic robotics, the absence of identifiable peer-reviewed publications in the public record is notable.

UNKNOWN: Whether Park Jong-hoon or other Neuromeka engineers have published peer-reviewed research on the CORE actuator design, harmonic reducer manufacturing methodology, cobot control algorithms, or safety architectures is not determinable from the available dossier. POSTECH's robotics-adjacent research groups are active in the literature, but a direct link between Neuromeka's commercial technology and published academic work is not established here.

EDITORIAL INFERENCE: The absence of a visible publication record does not mean no research is being conducted — many commercially focused robotics companies deliberately avoid publishing to protect intellectual property. However, it does mean that independent technical validation of Neuromeka's core technology claims (harmonic reducer quality, control algorithm performance, AI capability) is not available through the academic literature.

KIRS Research Report

VERIFIED: The Korea Institute of Robot and Convergence (KIRS) produced a research report on Neuromeka, available as a PDF ⁷. This is the closest available document to an independent technical assessment. The KIRS report corroborates the in-house component development claim as a key differentiator and references the OPTi welding deployment in shipbuilding. KIRS is a South Korean government-affiliated research institute, which means the report is more credible than vendor marketing material but may still reflect a promotional orientation toward domestic industry champions.

Company-linked papers

This module is being compiled — no data to show yet.

Authors & labs

This module is being compiled — no data to show yet.

Code & simulation

This module is being compiled — no data to show yet.

Datasets & benchmarks

This module is being compiled — no data to show yet.

---

06Media Evidence Library: What the Videos Prove

The research dossier contains zero video entries (count: 0). No video evidence was available for analysis in the preparation of this report.

EDITORIAL NOTE: The absence of video evidence in the dossier does not mean no videos exist. Neuromeka maintains a corporate website and is likely present on YouTube and trade media platforms. However, consistent with this report's evidence discipline, no claims about demonstrated capabilities are drawn from videos not reviewed and assessed in the research process.

What can be said about media evidence from non-video sources:

The Hannover Messe 2024 company profile ⁸ is a trade-fair document prepared for an audience of industrial buyers and engineers. It contains product specifications and application descriptions that are more technically specific than typical marketing collateral, and it has been treated accordingly as a higher-credibility source than press releases.

The Robotics 24/7 topic page for Neuromeka ¹⁴ indicates that the company has received coverage in English-language trade media, but the specific articles and their content are not detailed in the dossier.

The DN Automotive deployment ¹³ is covered by The Elec, an English-language Korean technology news outlet. This constitutes independent journalistic confirmation of a named customer deployment, which is a meaningful evidentiary standard.

EDITORIAL INFERENCE: A company at Neuromeka's stage of commercial development and with its trade-fair presence would be expected to have demonstration videos of the Indy series performing machine tending, the OPTi series performing welding, and the NURI AMR navigating a factory floor. The absence of these from the dossier is a research coverage gap, not evidence that such demonstrations do not exist. Any future assessment should incorporate direct video analysis.

Media library

This module is being compiled — no data to show yet.

---

07Commercial Reality

Revenue and Financial Position

The financial picture is the most important and most contested element of the Neuromeka commercial story.

VERIFIED: Trailing twelve-month revenue is KRW 18.77–18.95 billion (approximately USD 13.7–13.8 million at prevailing rates), down approximately 25% year-on-year from KRW 25.27 billion ⁶⁹. The net loss for the same period is KRW 40.28 billion (approximately USD 29.3 million) ⁶⁹. These figures are from public market filings and are not disputed.

The following table contextualises these figures:

The loss-to-revenue ratio is striking. A net loss of KRW 40.28 billion against revenue of KRW 18.95 billion implies that for every unit of revenue generated, the company is spending more than three units in total. This is not unusual for a technology company in a deliberate investment phase, but it requires a credible path to margin improvement that is not yet visible in the public record.

EDITORIAL INFERENCE: The market capitalisation of approximately KRW 623 billion against trailing revenue of approximately KRW 18.95 billion implies a price-to-sales multiple of roughly 33x. This valuation is consistent with the market pricing in significant future growth expectations — humanoid platform optionality, international expansion, CORE actuator OEM revenue — rather than current business fundamentals. It is a speculative valuation, not a fundamentals-based one.

Market Position Claim

COMPANY CLAIM: Neuromeka claims the number-one annual revenue position in Korea's collaborative robot market for 2024 ¹².

EDITORIAL INFERENCE: This claim is not independently verified. The domestic Korean cobot market includes Doosan Robotics (a subsidiary of Doosan Group, KOSDAQ-listed separately), Rainbow Robotics (acquired by Samsung Electronics), and international players including Universal Robots, Fanuc, and ABB. Doosan Robotics in particular is a well-capitalised competitor with strong domestic manufacturing relationships. If Neuromeka's claim of market leadership is accurate, it speaks to the fragmented and relatively small size of the Korean cobot market rather than to Neuromeka's absolute scale. A 25% revenue decline in the year following a claimed number-one position is not consistent with a company consolidating market leadership.

Confirmed Deployments

The DN Automotive deployment is the strongest piece of commercial evidence in the dossier. DN Automotive is a real, named customer with a confirmed mass-production deployment, and the subsequent DN Solutions investment ¹¹ reinforces the commercial relationship within the DN group ecosystem. This is a meaningful anchor customer.

EDITORIAL INFERENCE: The shipbuilding and F&B deployments are confirmed at the sector level but lack named customers. In the context of evaluating commercial traction, unnamed deployments carry less weight than named ones. The total confirmed named-customer count in the public record is one (DN Automotive).

Go-to-Market Model

VERIFIED: Neuromeka operates both direct sales and the IndyGO leasing/subscription model, with the latter explicitly targeting SME manufacturers who cannot absorb large capital expenditure ⁸. The monthly lease from €1,000 for the Indy7 ⁵ positions the product at approximately the same monthly cost as a mid-level skilled worker in some European markets, which is the standard cobot leasing value proposition.

VERIFIED: European distribution is active through Unchained Robotics, a German-based cobot marketplace ⁵. This is a third-party distribution channel, not a direct sales operation, which is appropriate for a company at this stage of European market entry but limits Neuromeka's control over the customer relationship and margin capture.

UNKNOWN: The number of active leasing customers, the geographic distribution of the installed base, the average contract size, and the renewal rate for IndyGO subscriptions are not publicly disclosed.

DN Solutions Investment

VERIFIED: In March 2025, DN Solutions invested KRW 5 billion (approximately USD 3.7 million) in Neuromeka ¹¹. DN Solutions is a major South Korean machine tool manufacturer. The investment is described as aimed at enhancing collaborative robotics and automation capability.

EDITORIAL INFERENCE: A machine tool manufacturer investing in a cobot company is a classic vertical integration or ecosystem play: DN Solutions likely intends to offer integrated machine-tending solutions combining its CNC machines with Neuromeka cobots. This is a commercially logical relationship and provides Neuromeka with both capital and a route to machine tool OEM bundling. However, KRW 5 billion is a modest investment relative to Neuromeka's loss rate and does not materially change the cash runway picture on its own.

Customers & deployments

DN AutomotiveAutomotive Manufacturer

First mass-production deployment of Neuromeka collaborative robots on DN Automotive's production line, with full automation confirmed.

---

Part 2 of this report (Sections 8–14) covers Markets and Use Cases, Competitive Landscape, Geopolitical Context, Hype vs Reality, Future Scenarios, Monitoring Checklist, and Sources.

08Markets and Use Cases

Neuromeka's commercial footprint spans three primary verticals — industrial manufacturing, food and beverage service automation, and specialised welding — with a nascent presence in media and art installations. Each vertical reflects a different commercial logic, and the evidence base for each varies considerably in depth.

Industrial Manufacturing: The Core Revenue Engine

The most substantiated deployment is in automotive component manufacturing. DN Automotive, a Tier 1 supplier in South Korea's automotive supply chain, has confirmed a mass-production deployment of Neuromeka cobots on its production line ¹³. The application is machine tending — specifically, loading and unloading of parts in a repeating cycle — which is among the most commercially mature cobot use cases globally. The deployment is significant not because the task is technically novel, but because mass-production automotive environments impose strict cycle-time, uptime, and quality requirements that filter out immature products. Confirmation from an independent news source ¹³ and corroboration from the official site ¹ give this deployment the highest evidentiary weight of any Neuromeka commercial claim.

The DN Solutions investment of KRW 5 billion (approximately $3.7 million) in March 2025 ¹¹ deepens this relationship. DN Solutions is a major South Korean machine tool manufacturer, and its financial stake in Neuromeka signals an intent to integrate cobot capability into its own machine tool ecosystem — a common strategy in the sector where machine tool OEMs seek to offer automated loading cells alongside their cutting machines. This creates a potential distribution channel that extends beyond Neuromeka's direct sales force, though the commercial terms of any reseller or integration agreement have not been publicly disclosed.

Shipbuilding welding represents the second confirmed industrial deployment. The KIRS research report ⁷ and the Hannover Messe company profile ⁸ both reference welding applications in shipbuilding block fabrication, a sector where South Korea holds global leadership through Hyundai Heavy Industries, Samsung Heavy Industries, and DSME. Welding in shipbuilding is technically demanding: weld paths are long, access is constrained, and quality standards are governed by classification society rules. Neuromeka's OPTi welding cobot series, combined with 3D camera guidance, is positioned for this application. However, named customer confirmation in shipbuilding has not been independently verified in the available dossier — the claim is plausible given South Korea's industrial geography, but should be treated as a company claim rather than a verified deployment.

Food and Beverage Service Automation

Neuromeka has pursued NSF certification for its cobots, a food-safety standard that is a prerequisite for deployment in food processing and food service environments ¹⁰. The NSF certification is a verified fact — it is a third-party regulatory credential, not a self-assessment. This positions the Indy series for use in food handling, packaging, and service applications.

The F&B service vertical is commercially attractive in South Korea, where labour costs in food service have risen sharply and the government has actively promoted automation subsidies for small and medium enterprises. Neuromeka's IndyGO leasing model, offering robots from approximately €1,000 per month ⁵, is directly calibrated to SME economics: a small restaurant or food processing facility cannot justify a capital purchase of €23,400 but may accept a monthly operating cost comparable to one part-time employee.

The evidence for actual F&B deployments in the dossier is thin. The NSF certification is confirmed; specific named customers in food service are not publicly disclosed ¹². The sector is referenced in company marketing materials and the KIRS report ⁷, but without independent customer confirmation, F&B service should be classified as a targeted market rather than a proven deployment vertical.

Welding and Shipbuilding

The OPTi series is Neuromeka's most specialised product line, designed explicitly for welding applications rather than general-purpose manipulation. The integration of 3D camera vision for weld seam tracking is a meaningful technical differentiator in this context: shipbuilding and heavy fabrication involve workpieces that are not perfectly consistent, and a robot that can adapt its path to actual seam geometry is more useful than one that follows a fixed programme. The Hannover Messe profile ⁸ describes this capability, though independent validation of its performance in production conditions is not available in the dossier.

South Korea's shipbuilding sector is a logical target market for a domestic cobot manufacturer. The industry faces a structural labour shortage in welding trades, driven by an ageing workforce and the physical demands of the work. Government and industry bodies have both identified robotic welding as a priority. Neuromeka's domestic positioning, combined with cultural and logistical advantages over foreign competitors, gives it a credible route to this market. Whether it has converted that opportunity into significant revenue is not determinable from public data.

Media, Art, and Demonstration Applications

The KIRS report ⁷ and company materials reference deployments in media and art contexts — robotic installations, interactive displays, and similar non-industrial applications. These are commercially marginal but serve a brand-building function, demonstrating dexterity and programmability to audiences beyond manufacturing engineers. They do not represent a meaningful revenue vertical and are not treated as such in this analysis.

Geographic Market

Neuromeka's primary market is South Korea, where it claims the number one revenue position in the collaborative robot segment for 2024 ¹². The claim is not independently verified, and the financial data showing a 25% revenue decline ⁶ complicates the narrative. The company has exhibited at Hannover Messe ⁸, indicating European market ambitions, and the Indy7 is listed for sale in euros on at least one European robotics marketplace ⁵, suggesting active distribution in Europe. The scale of international revenue relative to domestic revenue is not publicly disclosed.

The IndyGO leasing model appears designed partly for international market entry: a lower upfront commitment reduces the barrier for integrators and end users unfamiliar with the brand. Whether this has translated into meaningful international sales volumes is unknown.

09Competitive Landscape

Neuromeka operates in one of the most contested segments of the global robotics market. The collaborative robot category was effectively created by Universal Robots in 2008, and the decade since has seen the entry of dozens of manufacturers across Europe, North America, China, and Asia-Pacific. Neuromeka's competitive position must be assessed on at least three levels: global cobot leaders, regional Asian competitors, and the specific South Korean domestic market.

Global Cobot Leaders

Universal Robots (acquired by Teradyne in 2015) remains the global market share leader by unit volume and installed base. Its UR3, UR5, UR10, and UR16 series cover payload classes from 3 kg to 16 kg, with a mature ecosystem of end-of-arm tooling, software integrators, and certified system integrators numbering in the thousands globally. The UR ecosystem advantage is structural: a manufacturer choosing a cobot also chooses an integrator network, and Universal Robots' network depth is unmatched. Neuromeka's Indy7 (7 kg payload, €23,400) competes directly in price and payload class with the UR10e, but cannot match the integrator ecosystem depth.

FANUC, Yaskawa, and ABB each offer cobot lines (FANUC CRX, Yaskawa HC series, ABB GoFa/SWIFTI) backed by global service networks and deep relationships with automotive OEMs. These are not Neuromeka's primary competitive threat in the SME segment, but they are formidable in large-enterprise accounts.

Chinese Competitors

The most acute competitive pressure on Neuromeka's pricing and technology positioning comes from Chinese manufacturers. AUBO Robotics, Doosan Robotics (South Korean, discussed below), Elite Robots, and Jaka Robotics have all expanded internationally with products that match or undercut Western and Korean cobots on price. Chinese manufacturers benefit from domestic supply chains for motors, reducers, and electronics that are structurally lower cost than South Korean equivalents.

Neuromeka's claim of 100% in-house component development ¹² — including motors, harmonic reducers, and smart actuators — is positioned as a quality and supply-chain resilience differentiator. This is a credible argument in the context of geopolitical supply chain risk, but it also means Neuromeka bears the full fixed cost of component manufacturing without the scale economies that a high-volume Chinese competitor can achieve.

South Korean Domestic Competition

The most directly relevant competitive context is the South Korean cobot market, where Neuromeka claims the number one revenue position for 2024 ¹². The principal domestic competitor is Doosan Robotics (KOSDAQ: 454910), which is better capitalised, has a larger product range (H2017, H2515, M1013, M0617, A0509), and benefits from the Doosan Group's industrial relationships and balance sheet. Doosan Robotics went public in 2023 at a significantly higher valuation than Neuromeka and has pursued an aggressive international expansion strategy.

The competitive dynamics between Neuromeka and Doosan Robotics in the domestic market are not fully resolvable from public data. Neuromeka's claim of the number one revenue position, if accurate, would be a meaningful competitive statement. However, the 25% revenue decline in the most recent period ⁶ and the absence of independent market share data make this claim difficult to assess with confidence.

Hanwha Robotics (formerly Hanwha Precision Machinery) is a third South Korean competitor, with the HCR series of cobots and the backing of the Hanwha Group conglomerate. Hanwha's industrial relationships and financial resources represent a structural advantage over an independent company of Neuromeka's scale.

Competitive Positioning Summary

Neuromeka's sustainable competitive advantages are narrow but real: domestic Korean market knowledge and relationships, in-house component integration (relevant for customisation and supply chain control), the OPTi welding specialisation, and the IndyGO leasing model for SME access. None of these is a durable moat against a well-capitalised competitor that chooses to prioritise the Korean market.

Competitive comparison

Robot	Maker	Autonomy	Conf.
iRobot Roomba Combo 10 Max	iRobot	Autonomous	0.90
Mobile ALOHA (Stanford)	Stanford University	Teleoperated	0.90
1X NEO	1X Technologies	Remote-Assisted	0.90

10Geopolitical Context and Constraints

South Korea's Industrial Robotics Policy Environment

South Korea is among the world's most robot-dense manufacturing economies, with robot density in manufacturing consistently ranking in the top three globally alongside Singapore and Japan. The government has treated industrial robotics as a strategic sector, with the Ministry of Trade, Industry and Energy (MOTIE) and the Korea Institute of Robot and Convergence (KIRO) providing funding, certification infrastructure, and market development support. The KIRS research report on Neuromeka ⁷ is itself a product of this policy ecosystem — state-sponsored research bodies actively profile and promote domestic robotics companies.

This environment is structurally favourable for Neuromeka. Domestic procurement preferences, government-subsidised automation programmes for SMEs, and the concentration of target industries (automotive, shipbuilding, electronics) within South Korea's industrial geography all reduce the cost of market development relative to a foreign entrant.

US-China Technology Tensions and Supply Chain Implications

The broader US-China technology decoupling creates a complex environment for South Korean robotics manufacturers. On one hand, South Korean companies benefit from being perceived as a trusted alternative to Chinese suppliers in markets — particularly the United States and Europe — where procurement teams are scrutinising Chinese technology content in automation equipment. Neuromeka's in-house component development, including motors and harmonic reducers ¹⁴, is directly relevant here: a cobot with no Chinese-sourced critical components is a more defensible procurement choice for a US or European manufacturer operating under supply chain compliance requirements.

On the other hand, Chinese cobot manufacturers have been aggressively expanding internationally, and their price points are difficult to match without equivalent scale. The competitive pressure from Chinese manufacturers on Neuromeka's international ambitions is real and is likely to intensify.

Japan's Harmonic Drive Supply Chain

Harmonic reducers (strain wave gearing) are a critical component in cobot joints, and the global supply has historically been dominated by Harmonic Drive Systems of Japan. Neuromeka's claim to manufacture its own harmonic reducers in-house ¹⁴ is significant in this context: it removes a dependency on a Japanese supplier that could become a constraint in the event of trade friction or supply disruption. The KIRS report ⁷ identifies this as a key differentiator, and it is corroborated by the official parts page ⁴. The quality and performance of Neuromeka's in-house reducers relative to Harmonic Drive Systems' products is not independently benchmarked in the available dossier.

DN Solutions Investment: Strategic Alignment

The March 2025 investment by DN Solutions ¹¹ should be read in geopolitical as well as commercial terms. DN Solutions (formerly Doosan Machine Tools, subsequently spun off) is a major South Korean machine tool manufacturer with global customers. Its investment in Neuromeka creates a potential pathway for Neuromeka cobots to be specified alongside DN Solutions machine tools in international markets, including North America and Europe, where DN Solutions has an established sales presence. This is a meaningful distribution opportunity that does not depend on Neuromeka building its own international sales infrastructure from scratch.

Export Control and Dual-Use Considerations

Collaborative robots are not currently subject to significant export control restrictions in South Korea, the United States, or the European Union. The technology is widely available commercially and does not approach the thresholds that would trigger dual-use classification. This is unlikely to change in the near term for standard cobot payloads and speeds. The humanoid platform, if it develops toward higher-capability autonomous operation, could attract more scrutiny, but this is speculative at the current stage of development.

Currency and Macroeconomic Risk

Neuromeka reports in Korean Won, and its revenue base is primarily domestic. International sales priced in euros or dollars create currency exposure. The KRW has experienced periods of significant volatility, and a strengthening Won reduces the competitiveness of Korean exports on price. This is a standard risk for any Korean exporter and is not specific to Neuromeka, but it is relevant to the economics of the IndyGO leasing model in European markets.

11The Hype, the Real and the Ugly

The Hype

Neuromeka's marketing language contains claims that are materially inconsistent with the evidence available in the public domain. The most significant is the assertion that its robots "autonomously judge and perform tasks through advanced AI technology, building an intelligent automation ecosystem" ¹². This claim, taken at face value, implies a level of open-ended AI-driven task autonomy that is not demonstrated by any independently verified deployment. The confirmed use cases — machine tending at DN Automotive, welding in shipbuilding — are programmed industrial automation tasks. The robot follows a programme; it does not judge novel situations or adapt to unstructured environments through AI inference. The autonomy verdict in this report is that Neuromeka's robots are genuinely autonomous in the industrial sense (they execute tasks without a human performing them), but the vendor's framing of "AI autonomy" is aspirational marketing language without evidentiary support ⁷.

The claim of "No. 1 annual revenue in Korea's collaborative robot market for 2024" ¹² is a second area of concern. The claim is not independently verified. The financial data shows revenue declining 25% year-on-year to approximately KRW 18.95 billion ⁶, which is inconsistent with the narrative of a dominant market leader. It is possible to be the largest player in a small, declining market while still losing money at scale — these claims are not logically contradictory — but the vendor's framing implies a strength that the financial data does not support. The market share claim should be treated as unverified until an independent market research source confirms it.

The humanoid platform is presented in company materials and award citations ⁷ as a significant technological achievement. The China Chapek Award for "Humanoid Robot Technology Innovation Product" ⁷ is a commercial trade award, not a peer-reviewed technical assessment. No independent technical evaluation of the humanoid platform's capabilities, performance envelope, or development stage is available in the dossier. The platform should be treated as a development-stage product, not a commercial offering.

The Real

The verified facts about Neuromeka are substantive. The company has been publicly listed on KOSDAQ since its IPO ⁶¹², which imposes financial disclosure obligations and provides a degree of transparency not available for private companies. The Indy7 specifications — 7 kg payload, 1,300 mm reach, ±0.1 mm repeatability — are published by an independent European robotics marketplace ⁵, not just by the vendor, which provides corroboration. The DN Automotive deployment is confirmed by an independent news source ¹³. The NSF food safety certification is a third-party credential ¹⁰. The CORE smart actuator's component integration — frameless motor, harmonic drive, brake, encoder, EtherCAT board, and driver in a single unit — is described consistently across multiple sources ⁴⁸.

The in-house component development claim ¹⁴ is credible and corroborated by the KIRS report ⁷, which identifies it as a genuine differentiator in the Korean market. Whether the performance of these components matches best-in-class external suppliers is not independently benchmarked, but the capability to manufacture them is not in dispute.

The DN Solutions investment ¹¹ is a real strategic signal. A machine tool manufacturer investing in a cobot company and taking a financial stake is a meaningful commercial relationship, not a press release partnership. The KRW 5 billion investment is material relative to Neuromeka's revenue base.

The Ugly

The financial picture is the most uncomfortable aspect of Neuromeka's current situation. A net loss of KRW 40.28 billion against revenue of approximately KRW 18.95 billion ⁶ represents a loss-to-revenue ratio of more than 2:1. This is not investment-phase spending in the manner of a venture-backed startup that is deliberately sacrificing near-term profit for growth — it is a public company with KOSDAQ listing obligations, a market capitalisation of approximately KRW 623 billion ⁶, and a revenue trajectory that is moving in the wrong direction. The gap between market capitalisation and revenue (a price-to-sales ratio of approximately 33x on a declining revenue base) reflects market expectations of future growth that are not yet visible in the financial results.

The 25% revenue decline is particularly concerning in a period when the global cobot market has been growing. If Neuromeka is losing domestic market share to Doosan Robotics or Hanwha Robotics while simultaneously claiming the number one position, the claim may refer to a historical period or a specific market segment definition that flatters the result. Alternatively, the decline may reflect project-based revenue lumpiness rather than structural share loss — but this distinction cannot be resolved from the available data.

The total external funding of approximately $36.5 million ¹² is modest for a company with this level of ambition and this scale of operating losses. The company is burning cash at a rate that will require either a return to revenue growth, additional capital raises, or both.

Claim tracker

Neuromeka achieved mass-production deployment of collaborative robots on the DN Automotive production lineSupported

The deployment is corroborated by both the official site [1] and an independent news report from thelec.net [13], confirming automation is complete on the DN Automotive line; specific scale (number of units) and ongoing performance outcomes remain unverified.

Neuromeka is the No. 1 annual revenue company in Korea's collaborative robot market for 2024Unknown

This claim originates solely from Neuromeka's own marketing [2][8]; no independent market research or third-party ranking substantiates it, and public financial data shows revenue declining ~25% YoY to ~KRW 18.95 billion with a net loss of KRW 40.28 billion [6], undermining the implied dominance narrative.

The Indy7 cobot has a 7 kg payload, 1,300 mm reach, ±0.1 mm repeatability, and 1 m/s max TCP speedUnknown

Specs are sourced from a third-party commerce listing (Unchained Robotics [5]) rather than Neuromeka's own site, lending some independence, but no certified test report or customer validation independently confirms these performance figures in real-world conditions.

Neuromeka's NURI3s mobile robot achieved NSF food-safety certification, enabling F&B service deploymentsSupported

NSF certification is confirmed by a Yahoo Finance news announcement [10], an independent press outlet, though the scale of actual F&B deployments following certification has not been independently verified.

Neuromeka's OPTi welding robots are deployed in shipbuilding block welding applicationsUnknown

Shipbuilding welding is listed as a deployment sector across multiple sources [7][8], but no independent customer confirmation, shipyard name, or third-party report substantiates an active, at-scale deployment beyond vendor-sourced descriptions.

DN Solutions invested $3.7M (KRW 5 billion) in Neuromeka in March 2025 to enhance collaborative robotics and automationSupported

The investment is confirmed by an independent news report (WOWTALE [11]); however, the strategic impact on product development or deployment scale has not yet been independently assessed.

12Future Scenarios

The following scenarios are editorial inferences from the available evidence. They are not forecasts and should not be treated as such. They are structured to assist strategic planning by identifying the conditions under which materially different outcomes become likely.

Scenario A: Strategic Acquisition or Deep Partnership (Probability: Moderate)

The DN Solutions investment ¹¹ may be the first step in a deeper integration or eventual acquisition. DN Solutions has a clear commercial rationale for owning a cobot capability: it allows the company to offer automated machine-tending cells as a complete product rather than a third-party integration. Neuromeka's market capitalisation of approximately KRW 623 billion ⁶ is large relative to its revenue, but if the stock price corrects toward fundamentals, an acquisition at a lower valuation becomes more attractive.

The conditions that would make this scenario more likely: continued revenue decline, additional strategic investment tranches from DN Solutions, and the emergence of a formal OEM or reseller agreement between the two companies. The conditions that would make it less likely: Neuromeka returning to revenue growth and demonstrating a credible path to profitability as an independent company.

Scenario B: Humanoid Platform Becomes a Credible Commercial Product (Probability: Low to Moderate, 3–5 Year Horizon)

Neuromeka has a humanoid platform and has received a trade award for it ⁷. The global humanoid robot market is attracting extraordinary capital and attention in 2025–2026, with Boston Dynamics, Figure AI, Agility Robotics, and others competing for early industrial deployments. If Neuromeka can leverage its in-house actuator technology and cobot manufacturing experience to produce a humanoid platform with credible industrial performance, it could access a market that is currently underserved by domestic Korean suppliers.

The conditions for this scenario: demonstrated hardware performance in independent testing, a named industrial customer willing to pilot the platform, and sufficient capital to sustain the development timeline. The current financial position ⁶ makes the capital condition the binding constraint. Without additional funding or a return to profitability in the cobot business, the humanoid programme may be curtailed.

Scenario C: Continued Erosion of Domestic Market Position (Probability: Moderate)

If Doosan Robotics and Hanwha Robotics continue to expand their domestic product ranges and distribution, and if Chinese competitors accelerate their penetration of the Korean SME market through aggressive pricing, Neuromeka's domestic revenue base could continue to decline. The IndyGO leasing model is a rational response to this pressure, but it converts upfront capital revenue into a recurring revenue stream that takes time to build. In the interim, the cash position deteriorates.

The conditions that would accelerate this scenario: Doosan Robotics launching a direct competitor to the IndyGO leasing model, Chinese manufacturers obtaining Korean safety certifications and establishing local service infrastructure, and Neuromeka failing to convert the DN Solutions relationship into a meaningful distribution channel.

Scenario D: International Expansion via Machine Tool Channel (Probability: Moderate, 2–4 Year Horizon)

The DN Solutions investment creates a potential pathway to international markets through DN Solutions' existing sales and service infrastructure in North America, Europe, and Asia-Pacific. If DN Solutions begins specifying Neuromeka cobots as the preferred automation option for its machine tool customers, Neuromeka gains access to a large installed base of potential customers without building its own international sales force.

This scenario is commercially attractive but depends on execution factors that are not publicly visible: the terms of any commercial agreement between the two companies, the willingness of DN Solutions' sales force to promote a cobot product alongside machine tools, and the competitive positioning of the Indy series against Universal Robots and FANUC CRX in the machine-tending application.

Scenario E: Financial Distress and Restructuring (Probability: Low to Moderate if Revenue Does Not Recover)

A net loss of KRW 40.28 billion against revenue of KRW 18.95 billion ⁶ is not sustainable indefinitely. If revenue does not recover toward the previous level of KRW 25.27 billion, and if no additional capital is raised, the company will face a cash constraint that limits its ability to invest in product development, sales, and the humanoid programme. KOSDAQ listing provides access to equity capital markets, but repeated dilutive capital raises would pressure the stock price and the interests of existing shareholders.

This scenario does not imply insolvency in the near term — the market capitalisation of KRW 623 billion ⁶ suggests the market is pricing in significant future value — but it does imply that the current operating model is not self-sustaining and requires either revenue recovery or external capital.

13What to Watch: A Live Monitoring Checklist

The following indicators are the most informative signals for tracking Neuromeka's strategic and commercial trajectory. They are prioritised by their evidentiary value relative to the key uncertainties identified in this report.

Financial Performance (Quarterly KOSDAQ Filings)

• Revenue trajectory: Is the 25% YoY decline reversing? A return to KRW 22–25 billion annual revenue would be a meaningful positive signal.
• Operating loss trend: Is the loss-to-revenue ratio narrowing? Any path to operating breakeven requires either revenue growth or cost reduction.
• Cash and equivalents: How many quarters of runway remain at the current burn rate?
• IndyGO recurring revenue disclosure: If the company begins separately disclosing subscription revenue, this would indicate the leasing model is gaining traction.

DN Solutions Relationship

• Any announcement of a formal OEM, reseller, or distribution agreement between DN Solutions and Neuromeka.
• Evidence of Neuromeka cobots being offered as an option in DN Solutions machine tool configurations.
• A second investment tranche from DN Solutions, which would signal deepening commitment.

Humanoid Platform Development

• Any independent technical evaluation or benchmarking of the humanoid platform.
• A named industrial customer announcing a pilot programme.
• Patent filings related to humanoid locomotion, manipulation, or control — these would indicate genuine R&D investment rather than a demonstration prototype.

Market Share Verification

• Publication of independent Korean cobot market data by KIRO, KIRS, or an international market research firm that either confirms or contradicts the number one revenue claim.
• Doosan Robotics' financial disclosures, which provide an indirect benchmark for the competitive landscape.

International Distribution

• New distributor or system integrator agreements in Europe, North America, or Southeast Asia.
• Evidence of Indy series products appearing in international integrator catalogues beyond the current European marketplace listing ⁵.
• Any US or EU regulatory certifications (UL, CE expansion) that would be prerequisites for broader international deployment.

Technology Development

• New patent grants (the current 39 applications ¹ have not all been granted; grant rates and the scope of granted claims matter more than application counts).
• Publication of peer-reviewed research by Neuromeka engineers or affiliated academics — the current dossier contains no research publications, which is a gap for a company claiming AI-driven autonomy.
• Any independent benchmarking of the CORE actuator's performance against Harmonic Drive Systems or competing in-house solutions.

Customer Announcements

• Named customer confirmations in shipbuilding welding, food and beverage service, or any new vertical.
• Any public case study or press release from a customer that can be independently verified.
• Evidence of repeat orders or fleet expansion from existing customers, particularly DN Automotive.

Competitive Threats

• Chinese cobot manufacturers obtaining Korean safety certifications or establishing Korean service infrastructure.
• Doosan Robotics or Hanwha Robotics launching a leasing or subscription model that directly competes with IndyGO.
• Any acquisition of a Korean cobot company by a foreign strategic buyer, which would signal that the sector is attracting M&A attention.

14Sources and Methodology

Sources

¹ 협동로봇, 산업용로봇, 자율이동로봇, 델타로봇 I 뉴로메카 Neuromeka — https://www.neuromeka.com/

² 대한민국 대표 협동로봇, 뉴로메카 Neuromeka | 회사소개 — https://www.neuromeka.com/about

³ 로봇 | ROBOT | Neuromeka 뉴로메카 — https://www.neuromeka.com/robot

⁴ 대한민국 대표 협동로봇, 뉴로메카 Neuromeka | 스마트액츄에이터 코어(CORE) — https://www.neuromeka.com/robotparts

⁵ Neuromeka Indy7 - Unchained Robotics — https://unchainedrobotics.de/en/products/robot/cobot/neuromeka-indy7

⁶ Neuromeka (KOSDAQ:348340) Stock Price & Overview — https://stockanalysis.com/quote/kosdaq/348340

⁷ 251017_Neuromeka_F.pdf — https://w4.kirs.or.kr/download/research_eng/251017_Neuromeka_F.pdf

⁸ Neuromeka Company Profile - HANNOVER MESSE — https://www.hannovermesse.de/apollo/hannover_messe_2024/obs/Binary/A1346244/Neuromeka_Company_Profile_EN%28videoless%29-3MB.pdf

⁹ Neuromeka Co., Ltd. (348340.KQ) Stock Price, News, Quote & History - Yahoo Finance — https://finance.yahoo.com/quote/348340.KQ

¹⁰ Neuromeka Attains NSF Certification and Forges Strategic Partnership — https://finance.yahoo.com/news/neuromeka-attains-nsf-certification-forges-193700972.html

¹¹ DN Solutions Invests $3.7M in Neuromeka to Enhance Collaborative Robotics & Automation - WOWTALE — https://en.wowtale.net/2025/03/18/230274

¹² Neuromeka - 2026 Company Profile & Team - Tracxn — https://tracxn.com/d/companies/neuromeka/__rTbD4Mrzr5EPm7IBekP4gl22Mao88JtfO8VoxRrw2OE

¹³ Neuromeka Deploys Collaborative Robot Automation on DN Automotive Production Line — https://www.thelec.net/news/articleView.html?idxno=11207

¹⁴ Neuromeka News and Resources - Robotics 24/7 — https://www.robotics247.com/topic/tag/Neuromeka

Methodology

This report was produced under Max Robotics' standard editorial methodology for premium deep reports. The research dossier was gathered on 22 June 2026 and contains 14 numbered sources across official company materials, financial data providers, trade publications, a government-affiliated research report, a trade show company profile, and a third-party robotics marketplace listing. The dossier contains no peer-reviewed research publications and no video evidence, which are noted as gaps where relevant.

Evidence Classification

All factual claims in this report are classified according to the following scheme, applied consistently throughout:

Specific Methodological Constraints

The financial data in this report derives from KOSDAQ public market disclosures as aggregated by StockAnalysis.com ⁶ and Yahoo Finance ⁹. These are treated as verified facts given the mandatory disclosure obligations of a listed company. The market capitalisation figure reflects a specific point in time and will have changed by the time of reading.

The KIRS research report ⁷ is produced by the Korea Institute of Robot and Convergence, a government-affiliated body. It is treated as a more reliable source than company marketing materials, but it is not a fully independent commercial analysis — it is produced within a policy ecosystem that has an interest in promoting domestic robotics companies. Claims in the KIRS report that are not corroborated by other sources are treated as company claims rather than verified facts.

The Hannover Messe company profile ⁸ is a company-submitted document for a trade exhibition. It is treated as a primary company source, not an independent one, except where specific technical specifications (such as the NURI3s specs) are sufficiently precise and consistent with other sources to warrant higher confidence.

No video evidence was available in the dossier. No peer-reviewed publications by Neuromeka researchers were identified. These are material gaps for a company making claims about AI-driven autonomy and advanced technology development. The absence of published research is noted but does not, by itself, constitute evidence that the research does not exist — it may simply not be publicly accessible in English-language sources.

The autonomy classification of "Autonomous" in the industrial sense reflects the consensus